{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:16:48Z","timestamp":1790173008457,"version":"4.1.0"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2013,10,10]],"date-time":"2013-10-10T00:00:00Z","timestamp":1381363200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0075694","type":"journal-article","created":{"date-parts":[[2013,10,11]],"date-time":"2013-10-11T16:15:59Z","timestamp":1381508159000},"page":"e75694","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":27,"title":["Expression of IL-27 by Tumor Cells in InvasCutaneous and Metastatic Melanomas"],"prefix":"10.1371","volume":"8","author":[{"given":"Julie","family":"Gonin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Carlotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Audebourg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Radenen-Bussi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Caignard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Fran\u00e7oise","family":"Avril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-C\u00e9cile","family":"Vacher-Lavenu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9rique","family":"Larousserie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Devergne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,10,10]]},"reference":[{"key":"ref1","first-page":"241","article-title":"A new era : melanoma genetics and therapeutics","volume":"223","author":"JM Ko","year":"2011","journal-title":"J Pathol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2217\/imt.10.46","article-title":"Antimelanoma immunotherapy : clinical and preclinical applications of IL-12 family members","volume":"2","author":"H Nagai","year":"2010","journal-title":"Immunotherapy"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Xu M, Mizoguchi I, Morishima N, Chiba Y, Mizuguchi J, <etal>et al<\/etal>.. (2010) Regulation of antitumor immune responses by the IL-12 family cytokines, IL-12, IL-23, and IL-27. Clin Dev Immunol pii: 832454.","DOI":"10.1155\/2010\/832454"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1128\/JVI.70.2.1143-1153.1996","article-title":"A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes","volume":"70","author":"O Devergne","year":"1996","journal-title":"J Virol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1074-7613(02)00324-2","article-title":"IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells","volume":"16","author":"S Pflanz","year":"2002","journal-title":"Immunity"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.immuni.2012.11.003","article-title":"Interleukin-27 : balancing protective and pathological immunity","volume":"37","author":"CA Hunter","year":"2012","journal-title":"Immunity"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"605483","DOI":"10.1155\/2010\/605483","article-title":"A pivotal role for interleukin-27 in CD8+ T cell functions and the generation of cytotoxic T lymphocytes","volume":"2010","author":"N Morishima","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.4049\/jimmunol.175.3.1686","article-title":"Augmentation of effector CD8+ T cell generation with enhanced granzyme B expression by IL-27","volume":"175","author":"N Morishima","year":"2005","journal-title":"J Immunol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/eji.201040804","article-title":"IL-27 increases the proliferation and effector functions of human na\u00efve CD8+ T lymphocytes and promotes their development into Tc1 cells","volume":"41","author":"R Schneider","year":"2011","journal-title":"Eur J Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"9093","DOI":"10.1128\/JVI.78.17.9093-9104.2004","article-title":"Adjuvant activities of novel cytokines, interleukin-23 (IL-23) and IL-27, for induction of hepatitis C virus-specific cytotoxic T lymphocytes in HLA-A*0201 transgenic mice","volume":"78","author":"M Matsui","year":"2004","journal-title":"J Virol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.4049\/jimmunol.0902371","article-title":"IL-12 and IL-27 sequential gene therapy via intramuscular electroporation delivery for eliminating distal aggressive tumors","volume":"184","author":"S Zhu","year":"2010","journal-title":"J Immunol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1158\/0008-5472.CAN-03-2084","article-title":"Potent antitumor activity of interleukin-27","volume":"64","author":"M Hisada","year":"2004","journal-title":"Cancer Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/ijc.20848","article-title":"Expression of IL-27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animals","volume":"115","author":"M Chiyo","year":"2005","journal-title":"Int J Cancer"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"6217","DOI":"10.4049\/jimmunol.0901272","article-title":"IL-27 directly restrains lung tumorigenicity by suppressing cyclooxygenase-2-mediated activities","volume":"183","author":"M-Y Ho","year":"2009","journal-title":"J Immunol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"7170","DOI":"10.4049\/jimmunol.173.12.7170","article-title":"IL-27 mediates complete regression of orthotopic primary and metastatic murine neuroblastoma tumors : role for CD8+ T cells","volume":"173","author":"R Salcedo","year":"2004","journal-title":"J Immunol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.4049\/jimmunol.0800471","article-title":"Immunologic and therapeutic synergy of IL-27 and IL-2 : enhancement of T cell sensitization, tumor-specific CTL reactivity and complete regression of disseminated neuroblastoma metastases in the liver and bone marrow","volume":"182","author":"R Salcedo","year":"2009","journal-title":"J Immunol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"6395","DOI":"10.1158\/0008-5472.CAN-05-4087","article-title":"Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma","volume":"66","author":"S Oniki","year":"2006","journal-title":"Cancer Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"7317","DOI":"10.4049\/jimmunol.176.12.7317","article-title":"Antiangiogenic and antitumor activities of IL-27","volume":"176","author":"M Shimizu","year":"2006","journal-title":"J Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"6217","DOI":"10.4049\/jimmunol.0901272","article-title":"IL-27 directly restrains lung tumorigenicity by suppressing cyclooxygenase-2-mediated activities","volume":"183","author":"MY Ho","year":"2009","journal-title":"J Immunol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"vi14","DOI":"10.1093\/annonc\/mdp256","article-title":"Staging of cutaneous melanoma","volume":"20","author":"P Mohr","year":"2009","journal-title":"Ann Oncol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/S0002-9440(10)63023-4","article-title":"Expression of Epstein-Barr virus-induced gene 3, an interleukin-12 p40-related molecule, throughout human pregnancy: involvement of syncytiotrophoblasts and extravillous trophoblasts","volume":"159","author":"O Devergne","year":"2001","journal-title":"Am J Pathol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/path.1508","article-title":"Expression of IL-27 in human Th1-associated granulomatous diseases","volume":"202","author":"F Larousserie","year":"2004","journal-title":"J Pathol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0002-9440(10)62340-1","article-title":"Analysis of interleukin-27 (EBI3\/p28) expression in Epstein-Barr virus- and human T-cell leukemia virus type 1-associated lymphomas : heterogeneous expression of EBI3 subunit by tumoral cells","volume":"166","author":"F Larousserie","year":"2005","journal-title":"Am J Pathol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1158\/1078-0432.CCR-10-2084","article-title":"Unique functional status of natural killer cells in metastatic stage IV melanoma patients and its modulation by chemotherapy","volume":"17","author":"G Fregni","year":"2011","journal-title":"Clin Cancer Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/ni1537","article-title":"Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10","volume":"8","author":"JS Stumhofer","year":"2007","journal-title":"Nat Immunol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1038\/ni1540","article-title":"Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells","volume":"8","author":"DC Fitzgerald","year":"2007","journal-title":"Nat Immunol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/ni1541","article-title":"A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells","volume":"8","author":"A Awasthi","year":"2007","journal-title":"Nat Immunol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.4049\/jimmunol.0900568","article-title":"IL-27 is a key regulator of IL-10 and IL-17 production by human CD4+ T cells","volume":"183","author":"G Murugaiyan","year":"2009","journal-title":"J Immunol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1755-148X.2008.00450.x","article-title":"Transforming growth factor-\u00df in cutaneous melanoma","volume":"21","author":"D Javelaud","year":"2008","journal-title":"Pigement Cell Melanoma Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/(SICI)1097-0215(19960529)66:5<607::AID-IJC4>3.0.CO;2-X","article-title":"Interleukin-10 production in malignant melanoma : preferential detection of IL-10 secreting tumor cells in metastatic lesions","volume":"66","author":"W Dummer","year":"1996","journal-title":"Int J Cancer"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/modpathol.2011.5","article-title":"IL-10 expression by primary tumor cells correlates with melanoma progression from radial to vertical growth phase and development of metastic competence","volume":"24","author":"E Itakura","year":"2011","journal-title":"Mod Pathol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1189\/jlb.1209788","article-title":"IL-27 renders DC immunosuppressive by induction of B7-H1","volume":"89","author":"S Karakhanova","year":"2011","journal-title":"J Leukoc Biol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.immuni.2012.03.024","article-title":"Interleukin-27 priming of T cells controls IL-17 production in <italic>trans<\/italic> via induction of the ligand PD-L1","volume":"36","author":"K Hirahara","year":"2012","journal-title":"Immunity"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/cncr.24899","article-title":"Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma","volume":"116","author":"R Hino","year":"2010","journal-title":"Cancer"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1002\/cncr.25747","article-title":"Overall survival and PD-L1 expression in metastasized malignant melanoma","volume":"117","author":"J Gadiot","year":"2011","journal-title":"Cancer"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.4049\/jimmunol.1003588","article-title":"IL-27 and IL-21 are associated with T cell IL-10 responses in human visceral leishmaniasis","volume":"186","author":"NA Ansari","year":"2011","journal-title":"J Immunol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cyto.2011.04.020","article-title":"IL-27-producing CD14(+) cells infiltrate inflamed joints of rheumatoid arthritis and regulate inflammation and chemotactic migration","volume":"55","author":"S Tanida","year":"2011","journal-title":"Cytokine"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/path.1217","article-title":"Frequent expression of the Epstein-Barr virus (EBV)-induced gene, EBI3, an IL-12 p40-related cytokine, in Hodgkin and Reed-Sternberg cells","volume":"198","author":"G Niedobitek","year":"2002","journal-title":"J Pathol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/path.1995","article-title":"Variable expression of Epstein-Barr virus-induced gene 3 during normal B-cell differentiation and among B-cell lymphomas","volume":"209","author":"F Larousserie","year":"2006","journal-title":"J Pathol"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Gonin J, Larousserie F, Bastard C, Picquenot JM, Couturier J, <etal>et al<\/etal>.. (2011) Epstein-Barr virus-induced gene 3 (EBI3) : a novel diagnosis marker in Burkitt lymphoma and diffuse large B-cell lymphoma, PloS ONE, e24617.","DOI":"10.1371\/journal.pone.0024617"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"18502","DOI":"10.1073\/pnas.0702388104","article-title":"Transformation of hematopoietic cells and activation of Jak2-V617F by IL-27R, a component of a heterodimeric type 1 cytokine receptor","volume":"104","author":"A Pradhan","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"6527","DOI":"10.4049\/jimmunol.180.10.6527","article-title":"Antiproliferative activity of IL-27 on melanoma","volume":"180","author":"T Yoshimoto","year":"2008","journal-title":"J Immunol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"6325","DOI":"10.4049\/jimmunol.180.9.6325","article-title":"IL-27 activates human monocytes via STAT1 and suppresses IL-10 production but the inflammatory functions of IL-27 are abrogated by TLR and p38","volume":"180","author":"GD Kalliolias","year":"2008","journal-title":"J Immunol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.placenta.2007.06.004","article-title":"Expression of interleukin-27 by human trophoblast cells","volume":"28","author":"A Coulomb-L\u2019Hermin\u00e9","year":"2007","journal-title":"Placenta"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.4049\/jimmunol.178.6.3345","article-title":"Maternal acceptance of the fetus : true human tolerance","volume":"178","author":"I Guleria","year":"2007","journal-title":"J Immunol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","article-title":"Safety and activity of anti-PD-L1 antibody in patients with advanced cancer","volume":"366","author":"JR Brahmer","year":"2012","journal-title":"N Engl J Med"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safetey, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"SL Topalian","year":"2012","journal-title":"N Engl J Med"}],"updated-by":[{"DOI":"10.1371\/annotation\/e1a0e85e-e632-40f2-9925-e0b71eb18b56","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2013,11,7]],"date-time":"2013-11-07T00:00:00Z","timestamp":1383782400000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0075694","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T18:24:47Z","timestamp":1596651887000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0075694"}},"subtitle":[],"editor":[{"given":"Andrzej T.","family":"Slominski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,10,10]]},"references-count":47,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2013,10,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0075694","relation":{"correction":[{"id-type":"doi","id":"10.1371\/annotation\/e1a0e85e-e632-40f2-9925-e0b71eb18b56","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,10]]}}}